{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:40:43Z","timestamp":1740123643958,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T00:00:00Z","timestamp":1522800000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s10689-018-0081-7","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T00:37:54Z","timestamp":1522802274000},"page":"91-95","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hemangioblastoma in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome: a phenotypic overlap between VHL and HLRCC Syndromes"],"prefix":"10.1007","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5630-1994","authenticated-orcid":false,"given":"Eryn","family":"Dow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid M.","family":"Winship","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,4]]},"reference":[{"issue":"1","key":"81_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/neup.12316","volume":"37","author":"D Pierscianek","year":"2017","unstructured":"Pierscianek D, Wolf S, Keyvani K, El Hindy N, Stein KP, Sandalcioglu IE, Sure U, Mueller O, Zhu Y (2017) Study of angiogenic signaling pathways in hemangioblastoma. Neuropathology 37(1):3\u201311. \n                    https:\/\/doi.org\/10.1111\/neup.12316","journal-title":"Neuropathology"},{"key":"81_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/B978-0-444-62702-5.00010-X","volume":"132","author":"P Chittiboina","year":"2015","unstructured":"Chittiboina P, Lonser RR (2015) Von Hippel-Lindau disease. Handb Clin Neurol 132:139\u2013156. \n                    https:\/\/doi.org\/10.1016\/b978-0-444-62702-5.00010-x","journal-title":"Handb Clin Neurol"},{"issue":"6","key":"81_CR3","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1073\/pnas.051633798","volume":"98","author":"V Launonen","year":"2001","unstructured":"Launonen V, Vierimaa O, Kiuru M, Isola J, Roth S, Pukkala E, Sistonen P, Herva R, Aaltonen LA (2001) Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci USA 98(6):3387\u20133392. \n                    https:\/\/doi.org\/10.1073\/pnas.051633798","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"81_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/archderm.141.2.199","volume":"141","author":"NA Alam","year":"2005","unstructured":"Alam NA, Barclay E, Rowan AJ, Tyrer JP, Calonje E, Manek S, Kelsell D, Leigh I, Olpin S, Tomlinson IP (2005) Clinical features of multiple cutaneous and uterine leiomyomatosis: an underdiagnosed tumor syndrome. Arch Dermatol 141(2):199\u2013206. \n                    https:\/\/doi.org\/10.1001\/archderm.141.2.199","journal-title":"Arch Dermatol"},{"key":"81_CR5","volume-title":"GeneReviews(R)","author":"M Pithukpakorn","year":"1993","unstructured":"Pithukpakorn M, Toro JR (1993) Hereditary leiomyomatosis and renal cell cancer. In: Pagon RA, Adam MP, Ardinger HH et al (eds) GeneReviews(R). University of Washington, Seattle"},{"issue":"12","key":"81_CR6","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1177\/0022034515608168","volume":"94","author":"PN Kantaputra","year":"2015","unstructured":"Kantaputra PN, Kaewgahya M, Hatsadaloi A, Vogel P, Kawasaki K, Ohazama A, Ketudat Cairns JR (2015) GREMLIN 2 mutations and dental anomalies. J Dent Res 94(12):1646\u20131652. \n                    https:\/\/doi.org\/10.1177\/0022034515608168","journal-title":"J Dent Res"},{"issue":"6","key":"81_CR7","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.ajhg.2014.10.016","volume":"95","author":"R Law","year":"2014","unstructured":"Law R, Dixon-Salazar T, Jerber J, Cai N, Abbasi AA, Zaki MS, Mittal K, Gabriel SB, Rafiq MA, Khan V, Nguyen M, Ali G, Copeland B, Scott E, Vasli N, Mikhailov A, Khan MN, Andrade DM, Ayaz M, Ansar M, Ayub M, Vincent JB, Gleeson JG (2014) Biallelic truncating mutations in FMN2, encoding the actin-regulatory protein Formin 2, cause nonsyndromic autosomal-recessive intellectual disability. Am J Hum Genet 95(6):721\u2013728. \n                    https:\/\/doi.org\/10.1016\/j.ajhg.2014.10.016","journal-title":"Am J Hum Genet"},{"issue":"1","key":"81_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10689-015-9829-5","volume":"15","author":"BT Duong","year":"2016","unstructured":"Duong BT, Savarirayan R, Winship I (2016) Incidental diagnosis of HLRCC following investigation for Asperger Syndrome: actionable and actioned. Fam Cancer 15(1):25\u201329. \n                    https:\/\/doi.org\/10.1007\/s10689-015-9829-5","journal-title":"Fam Cancer"},{"issue":"5","key":"81_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrurol.2010.47","volume":"7","author":"WM Linehan","year":"2010","unstructured":"Linehan WM, Srinivasan R, Schmidt LS (2010) The genetic basis of kidney cancer: a metabolic disease. Nat Rev Urol 7(5):277\u2013285. \n                    https:\/\/doi.org\/10.1038\/nrurol.2010.47","journal-title":"Nat Rev Urol"},{"issue":"2","key":"81_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ccr.2005.06.017","volume":"8","author":"JS Isaacs","year":"2005","unstructured":"Isaacs JS, Jung YJ, Mole DR, Lee S, Torres-Cabala C, Chung YL, Merino M, Trepel J, Zbar B, Toro J, Ratcliffe PJ, Linehan WM, Neckers L (2005) HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8(2):143\u2013153. \n                    https:\/\/doi.org\/10.1016\/j.ccr.2005.06.017","journal-title":"Cancer Cell"},{"issue":"15","key":"81_CR11","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1093\/hmg\/ddi227","volume":"14","author":"PJ Pollard","year":"2005","unstructured":"Pollard PJ, Briere JJ, Alam NA, Barwell J, Barclay E, Wortham NC, Hunt T, Mitchell M, Olpin S, Moat SJ, Hargreaves IP, Heales SJ, Chung YL, Griffiths JR, Dalgleish A, McGrath JA, Gleeson MJ, Hodgson SV, Poulsom R, Rustin P, Tomlinson IP (2005) Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum Mol Genet 14(15):2231\u20132239. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddi227","journal-title":"Hum Mol Genet"},{"issue":"6","key":"81_CR12","doi-asserted-by":"publisher","first-page":"e21037","DOI":"10.1371\/journal.pone.0021037","volume":"6","author":"S Sudarshan","year":"2011","unstructured":"Sudarshan S, Shanmugasundaram K, Naylor SL, Lin S, Livi CB, O\u2019Neill CF, Parekh DJ, Yeh IT, Sun LZ, Block K (2011) Reduced expression of fumarate hydratase in clear cell renal cancer mediates HIF-2alpha accumulation and promotes migration and invasion. PLoS ONE 6(6):e21037. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0021037","journal-title":"PLoS ONE"},{"issue":"3","key":"81_CR13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/PAS.0000000000000776","volume":"41","author":"SR Williamson","year":"2017","unstructured":"Williamson SR, Grignon DJ, Cheng L, Favazza L, Gondim DD, Carskadon S, Gupta NS, Chitale DA, Kalyana-Sundaram S, Palanisamy N (2017) Renal cell carcinoma with chromosome 6p amplification including the TFEB gene: a novel mechanism of tumor pathogenesis? Am J Surg Pathol 41(3):287\u2013298. \n                    https:\/\/doi.org\/10.1097\/pas.0000000000000776","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"81_CR14","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nm0895-822","volume":"1","author":"O Iliopoulos","year":"1995","unstructured":"Iliopoulos O, Kibel A, Gray S, Kaelin WG Jr (1995) Tumour suppression by the human von Hippel-Lindau gene product. Nat Med 1(8):822\u2013826","journal-title":"Nat Med"},{"issue":"5","key":"81_CR15","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.humpath.2006.10.011","volume":"38","author":"HJ Lehtonen","year":"2007","unstructured":"Lehtonen HJ, Blanco I, Piulats JM, Herva R, Launonen V, Aaltonen LA (2007) Conventional renal cancer in a patient with fumarate hydratase mutation. Hum Pathol 38(5):793\u2013796. \n                    https:\/\/doi.org\/10.1016\/j.humpath.2006.10.011","journal-title":"Hum Pathol"},{"key":"81_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/cge.13014","author":"M Muller","year":"2017","unstructured":"Muller M, Ferlicot S, Guillaud-Bataille M, Le Teuff G, Genestie C, Deveaux S, Slama A, Poulalhon N, Escudier B, Albiges L, Soufir N, Avril MF, Gardie B, Saldana C, Allory Y, Gimenez-Roqueplo AP, Bressac-de Paillerets B, Richard S, Benusiglio PR (2017) Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers. Clin Genet. \n                    https:\/\/doi.org\/10.1111\/cge.13014","journal-title":"Clin Genet"},{"issue":"3","key":"81_CR17","doi-asserted-by":"publisher","first-page":"234","DOI":"10.5114\/fn.2014.45564","volume":"52","author":"M Li","year":"2014","unstructured":"Li M, Song J, Pytel P (2014) Expression of HIF-1 regulated proteins vascular endothelial growth factor, carbonic anhydrase IX and hypoxia inducible gene 2 in hemangioblastomas. Folia Neuropathol 52(3):234\u2013242","journal-title":"Folia Neuropathol"},{"key":"81_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nox034","author":"S Takayanagi","year":"2017","unstructured":"Takayanagi S, Mukasa A, Tanaka S, Nomura M, Omata M, Yanagisawa S, Yamamoto S, Ichimura K, Nakatomi H, Ueki K, Aburatani H, Saito N (2017) Differences in genetic and epigenetic alterations between von Hippel-Lindau disease-related and sporadic hemangioblastomas of the central nervous system. Neuro-oncology. \n                    https:\/\/doi.org\/10.1093\/neuonc\/nox034","journal-title":"Neuro-oncology"},{"key":"81_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-014-0167-x","author":"GM Shankar","year":"2014","unstructured":"Shankar GM, Taylor-Weiner A, Lelic N, Jones RT, Kim JC, Francis JM, Abedalthagafi M, Borges LF, Coumans J, Curry WT, Nahed BV, Shin JH, Paek SH, Park S, Stewart C, Lawrence MS, Cibulskis K, Thorner AR, Van Hummelen P, Stemmer-Rachamimov AO, Batchelor TT, Carter SL, Hoang MP, Santagata S, Louis DN, Barker FG II, Meyerson M, Getz G, Brastianos PK, Cahill DP (2014) Sporadic hemangioblastomas are characterized by cryptic VHL inactivation. Acta Neuropathol Commun. \n                    https:\/\/doi.org\/10.1186\/s40478-014-0167-x","journal-title":"Acta Neuropathol Commun"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-018-0081-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-018-0081-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-018-0081-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T05:59:32Z","timestamp":1567231172000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-018-0081-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,4]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["81"],"URL":"https:\/\/doi.org\/10.1007\/s10689-018-0081-7","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"type":"print","value":"1389-9600"},{"type":"electronic","value":"1573-7292"}],"subject":[],"published":{"date-parts":[[2018,4,4]]},"assertion":[{"value":"4 April 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}